Interaction of vasopressin with human blood platelets: dependency on Mg2+

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Arginine-vasopressin (AVP) is a hormone involved in various physiological processes.
• Platelet activation plays a crucial role in hemostasis and thrombosis.
• Phosphatidyl inositide signaling is a key pathway in cellular responses.

Purpose of the Study:

• To investigate the role of magnesium ions (Mg2+) in AVP-mediated signaling in human platelets.
• To determine if Mg2+ affects AVP binding to platelet receptors.
• To elucidate the mechanism by which AVP stimulates phosphatidyl inositide breakdown.

Main Methods:

• Incubation of human blood platelets with radiolabeled AVP ([3H]-AVP) and Mg2+.
• Measurement of [32P]-phosphatidic acid ([32P]-PA) accumulation.
• Quantification of specific [3H]-AVP binding to intact platelets.

Main Results:

• AVP induced accumulation of [32P]-PA in human platelets specifically in the presence of Mg2+.
• Mg2+ significantly enhanced the specific binding of [3H]-AVP to platelet membranes.
• The concentrations of Mg2+ required for half-maximal AVP-induced [32P]-PA accumulation and [3H]-AVP binding were comparable.

Conclusions:

• The stimulation of phosphatidyl inositide breakdown by AVP in human platelets is, at least partially, mediated by Mg2+-enhanced AVP binding.
• Mg2+ plays a critical role in modulating AVP receptor affinity and downstream signaling in platelets.